Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

NCT ID: NCT05409066

Last Updated: 2025-07-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

549 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-20

Study Completion Date

2029-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Follicular Lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this disease is incurable with conventional treatment and the disease recurs in almost all patients. This study will assess how safe and effective epcoritamab is in combination with lenalidomide and rituximab (R2) in treating adult participants with relapsed or refractory (R/R) FL. Adverse events and change in disease condition will be assessed.

Epcoritamab is an investigational drug being developed for the treatment of FL. Study doctors put the participants in 1 of 3 groups, called treatment arms. Each group receives a different treatment. Enrollment to one of the groups is closed. Around 500 adult participants with R/R FL will be enrolled in approximately 300 sites across the world.

Participants will receive R2 (375 mg/m\^2 intravenous infusion of rituximab up to 5 cycles and oral capsules of 20 mg lenalidomide for up to 12 cycles) alone or in combination with subcutaneous injections of epcoritamab for up to 12 cycles (each cycle is 28 days).

There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Follicular Lymphoma (FL)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Epcoritamab Dose A in Combination With R2

Participants will receive epcoritamab Dose A in combination with lenalidomide and rituximab (R2) for 12 cycles (each cycle is 28 days).

Group Type EXPERIMENTAL

Epcoritamab

Intervention Type DRUG

Subcutaneous Injection

Rituximab

Intervention Type DRUG

Intravenous Infusion

Lenalidomide

Intervention Type DRUG

Oral Capsules

Epcoritamab Dose B in Combination With R2

Participants will receive epcoritamab Dose B in combination with lenalidomide and rituximab (R2) for 12 cycles (each cycle is 28 days). Enrollment is closed for this arm.

Group Type EXPERIMENTAL

Epcoritamab

Intervention Type DRUG

Subcutaneous Injection

Rituximab

Intervention Type DRUG

Intravenous Infusion

Lenalidomide

Intervention Type DRUG

Oral Capsules

Lenalidomide and Rituximab (R2)

Participants will receive lenalidomide and rituximab (R2) for 12 cycles (each cycle is 28 days).

Group Type ACTIVE_COMPARATOR

Rituximab

Intervention Type DRUG

Intravenous Infusion

Lenalidomide

Intervention Type DRUG

Oral Capsules

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Epcoritamab

Subcutaneous Injection

Intervention Type DRUG

Rituximab

Intravenous Infusion

Intervention Type DRUG

Lenalidomide

Oral Capsules

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Eastern Cooperative Oncology Group (ECOG) performance status score 0 to 2.
* Participant has:

* Fluorodeoxyglucose-positron emission tomography (FDG-PET) scan demonstrating positive lesion compatible with computed tomography (CT) or magnetic resonance image (MRI)-defined anatomical tumor sites AND
* \>= 1 measurable nodal lesion (long axis \> 1.5 cm) or \>= 1 measurable extra-nodal lesion (long axis \> 1.0 cm) on CT scan or MRI.
* Histologically confirmed classic follicular lymphoma (FL) \[previously Grade 1 to 3a FL\] stage II, III, or IV with no evidence of histologic transformation to an aggressive lymphoma and CD20+ disease on most recent representative tumor biopsy based on the pathology report.
* Relapsed or refractory (R/R) disease to at least one prior systemic regimen that contained an anti-CD20 monoclonal antibody (mAb) in combination with chemotherapy. (Participant who received only prior anti-CD20 mAb monotherapy and/or radiation therapy is not eligible.)
* Eligible to receive R2 per investigator determination.
* Estimated Creatinine Clearance (CrCl) \>= 50 mL/min.

Exclusion Criteria

* Documented refractoriness to lenalidomide.
* Have lenalidomide exposure within 12 months prior to randomization.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AbbVie

INDUSTRY

Sponsor Role collaborator

Genmab

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

ABBVIE INC.

Role: STUDY_DIRECTOR

AbbVie

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University of Arizona Cancer Center - North Campus /ID# 228862

Tucson, Arizona, United States

Site Status

University of Arkansas for Medical Sciences /ID# 227198

Little Rock, Arkansas, United States

Site Status

Alta Bates Summit Medical Center for Research /ID# 229428

Berkeley, California, United States

Site Status

Beverly Hills Cancer Center /ID# 231535

Beverly Hills, California, United States

Site Status

Long Beach Memorial Medical Ct /ID# 228997

Long Beach, California, United States

Site Status

University of Southern California /ID# 227195

Los Angeles, California, United States

Site Status

Valkyrie Clinical Trials /ID# 268502

Los Angeles, California, United States

Site Status

Duplicate_Emory University /ID# 227299

Atlanta, Georgia, United States

Site Status

Hawaii Cancer Care - Waterfront Plaza /ID# 262448

Honolulu, Hawaii, United States

Site Status

Northwestern University Feinberg School of Medicine /ID# 227248

Chicago, Illinois, United States

Site Status

Goshen Center for Cancer Care /ID# 227189

Goshen, Indiana, United States

Site Status

Community Health Network, Inc. /ID# 259756

Indianapolis, Indiana, United States

Site Status

Our Lady Of The Lake Regional Medical Center /ID# 251393

Baton Rouge, Louisiana, United States

Site Status

University of Maryland, Baltimore /ID# 227191

Baltimore, Maryland, United States

Site Status

Massachusetts General Hospital /ID# 245233

Boston, Massachusetts, United States

Site Status

UMass Memorial Medical Center /ID# 227323

Worcester, Massachusetts, United States

Site Status

Henry Ford Hospital /ID# 227250

Detroit, Michigan, United States

Site Status

St. Luke's Hospital - Chesterfield /ID# 247817

Chesterfield, Missouri, United States

Site Status

Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana /ID# 251220

Billings, Montana, United States

Site Status

Morristown Medical Center /ID# 231427

Morristown, New Jersey, United States

Site Status

Roswell Park Cancer Institute /ID# 239128

Buffalo, New York, United States

Site Status

NYU Langone Hospital - Long Island /ID# 253343

Mineola, New York, United States

Site Status

NYU Laura and Isaac Perlmutter Cancer Center /ID# 227322

New York, New York, United States

Site Status

Icahn School of Medicine at Mount Sinai /ID# 227181

New York, New York, United States

Site Status

Memorial Sloan Kettering Cancer Center-Koch Center /ID# 227193

New York, New York, United States

Site Status

East Carolina University - Brody School of Medicine /ID# 227192

Greenville, North Carolina, United States

Site Status

University of Oklahoma, Stephenson Cancer Center /ID# 227325

Oklahoma City, Oklahoma, United States

Site Status

Baylor Sammons Cancer Center /ID# 261584

Dallas, Texas, United States

Site Status

Texas Oncology - Northeast Texas /ID# 265890

Tyler, Texas, United States

Site Status

Intermountain Healthcare LDS Hospital /ID# 259948

Salt Lake City, Utah, United States

Site Status

Virginia Commonwealth University Medical Center Main Hospital /ID# 227211

Richmond, Virginia, United States

Site Status

Fundaleu /Id# 229700

Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina

Site Status

Duplicate_CEMIC /ID# 229697

Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina

Site Status

Hospital Privado Universitario - Hospital Privado Centro Medico de Cordoba S.A. /ID# 229701

Córdoba, Córdoba Province, Argentina

Site Status

Clinica de Nefrologia, Urologia y Enfermedades Cardiovasculares /ID# 232124

Santa Fe, Santa Fe Province, Argentina

Site Status

Royal Prince Alfred Hospital /ID# 239272

Camperdown, New South Wales, Australia

Site Status

Nepean Hospital /ID# 239093

Kingswood, New South Wales, Australia

Site Status

Townsville University Hospital /ID# 231124

Douglas, Queensland, Australia

Site Status

Peninsula Private Hospital /ID# 238796

Frankston, Victoria, Australia

Site Status

Fiona Stanley Hospital /ID# 231122

Murdoch, Western Australia, Australia

Site Status

Royal Perth Hospital /ID# 230456

Perth, Western Australia, Australia

Site Status

Hollywood Private Hospital /ID# 251789

Perth, Western Australia, Australia

Site Status

Universitaetsklinikum St. Poelten /ID# 234015

Sankt Pölten, Lower Austria, Austria

Site Status

Landeskrankenhaus Salzburg-Universitaetsklinikum der PMU (LKH) /ID# 228366

Salzburg, Salzburg, Austria

Site Status

Ordensklinikum Linz GmbH Elisabethinen /ID# 247510

Linz, Upper Austria, Austria

Site Status

Uza /Id# 228521

Edegem, Antwerpen, Belgium

Site Status

Hospital La Louviere Site Jolimont - Helora /ID# 228520

La Louvière, Hainaut, Belgium

Site Status

Groupe Sante CHC - Clinique du MontLegia /ID# 230415

Liège, Liege, Belgium

Site Status

Vitaz /Id# 228525

Sint-Niklaas, Oost-Vlaanderen, Belgium

Site Status

Universitair Ziekenhuis Leuven /ID# 247780

Leuven, Vlaams-Brabant, Belgium

Site Status

Institut Jules Bordet /ID# 254676

Anderlecht, , Belgium

Site Status

AZ Turnhout - Campus Sint-Elisabeth /ID# 231628

Turnhout, , Belgium

Site Status

Hospital de Clinicas da Universidade Federal do Parana /ID# 228123

Curitiba, Paraná, Brazil

Site Status

Instituto Nacional de Cancer (INCA) /ID# 228706

Rio de Janeiro, Rio de Janeiro, Brazil

Site Status

Upeclin Fmb - Unesp /Id# 252912

Botucatu, São Paulo, Brazil

Site Status

Hospital Amaral Carvalho - Fundacao Doutor Amaral Carvalho /ID# 228129

Jaú, São Paulo, Brazil

Site Status

Real e Benemérita Associação Portuguesa de Beneficência /ID# 228121

São Paulo, São Paulo, Brazil

Site Status

Instituto D'Or de Pesquisa e Ensino - Regional Sao Paulo /ID# 252918

São Paulo, São Paulo, Brazil

Site Status

Fundacao Antonio Prudente - AC Camargo Cancer Center /ID# 228130

São Paulo, São Paulo, Brazil

Site Status

Instituto de Assistencia Medica ao Servidor Publico Estadual /ID# 230182

São Paulo, São Paulo, Brazil

Site Status

Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao /ID# 228127

São Paulo, São Paulo, Brazil

Site Status

Cross Cancer Institute /ID# 249080

Edmonton, Alberta, Canada

Site Status

BC Cancer - Victoria /ID# 228850

Victoria, British Columbia, Canada

Site Status

CSSS Alphonse-Desjardins, CHAU de Levis /ID# 229896

Lévis, Quebec, Canada

Site Status

CHUQ- Hôpital de l'Enfant-Jesus /ID# 231537

Québec, Quebec, Canada

Site Status

CISSSBSL -Hopital regional de Rimouski /ID# 229894

Rimouski, Quebec, Canada

Site Status

Peking University First Hospital /ID# 250517

Beijing, Beijing Municipality, China

Site Status

Peking University Third Hospital /ID# 230885

Beijing, Beijing Municipality, China

Site Status

Fujian Medical University Union Hospital /ID# 233919

Fuzhou, Fujian, China

Site Status

The First Affiliated Hospital of Xiamen University /ID# 238427

Xiamen, Fujian, China

Site Status

Sun Yat-Sen University Cancer Center /ID# 231463

Guangzhou, Guangdong, China

Site Status

Guangdong Provincial Peoples Hospital(Huifu Campus) /ID# 232512

Guangzhou, Guangdong, China

Site Status

Nanfang Hospital of Southern Medical University /ID# 230383

Guangzhou, Guangdong, China

Site Status

Fourth Hospital of Hebei Medical University /ID# 238657

Shijiazhuang, Hebei, China

Site Status

Henan Cancer Hospital /ID# 230459

Zhengzhou, Henan, China

Site Status

Union Hospital affiliated to Tongji Medical College of Huazhong University of Sc /ID# 234153

Wuhan, Hubei, China

Site Status

Hubei Cancer Hospital /ID# 232255

Wuhan, Hubei, China

Site Status

Hunan Cancer Hospital /ID# 232153

Changsha, Hunan, China

Site Status

The First Affiliated Hospital of Soochow University /ID# 232511

Suzhou, Jiangsu, China

Site Status

The Affiliated Hospital of Xuzhou Medical College /ID# 232513

Xuzhou, Jiangsu, China

Site Status

The First Affiliated Hospital of Nanchang University /ID# 231047

Nanchang, Jiangxi, China

Site Status

Jiangxi Provincial Cancer Hospital /ID# 232507

Nanchang, Jiangxi, China

Site Status

The First Hospital of China Medical University /ID# 232509

Shenyang, Liaoning, China

Site Status

Xijing Hospital /ID# 238650

Xi'an, Shaanxi, China

Site Status

Fudan University Cancer Hospital /ID# 250475

Shanghai, Shanghai Municipality, China

Site Status

Tianjin Cancer Hospital /ID# 230876

Tianjin, Tianjin Municipality, China

Site Status

Yunnan Cancer Hospital /ID# 232062

Kunming, Yunnan, China

Site Status

The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 230390

Hangzhou, Zhejiang, China

Site Status

The second affiliated hospital of Zhejiang University school of medicine /ID# 231250

Hangzhou, Zhejiang, China

Site Status

Zhejiang Cancer hospital /ID# 231389

Hangzhou, Zhejiang, China

Site Status

Fakultní nemocnice Hradec Králové - Sokolská /ID# 228269

Hradec Králové, Hradec Kralove, Czechia

Site Status

Všeobecná Fakultní Nemocnice v Praze /ID# 228565

Prague, Praha 17, Czechia

Site Status

Fakultni nemocnice Kralovske Vinohrady /ID# 228564

Prague, , Czechia

Site Status

Duplicate_Fakultni Nemocnice v Motole /ID# 228272

Prague, , Czechia

Site Status

Regionshospitalet Godstrup /ID# 227466

Herning, Central Jutland, Denmark

Site Status

Sygehus Lillebalt, Vejle /ID# 227404

Vejle, Region Syddanmark, Denmark

Site Status

CHU Clermont-Ferrand /ID# 238676

Clermont, Auvergne-Rhône-Alpes, France

Site Status

CHU de Rennes - PONTCHAILLOU /ID# 230356

Rennes, Brittany Region, France

Site Status

CHU Dijon /ID# 230354

Dijon, Cote-d Or, France

Site Status

CHU Limoges - Dupuytren 1 /ID# 231450

Limoges, Franche-Comte, France

Site Status

CHU NIMES - Hopital Caremeau /ID# 230351

Nîmes, Gard, France

Site Status

Centre Hospitalier Universitaire de Bordeaux /ID# 230347

Pessac, Gironde, France

Site Status

CHU Reims - Hôpital Robert Debre /ID# 248710

Reims, Marne, France

Site Status

CHRU Nancy - Hopitaux de Brabois /ID# 241595

Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France

Site Status

CHRU Lille - Hopital Claude Huriez /ID# 230353

Lille, Nord, France

Site Status

IUCT Oncopole /ID# 233486

Toulouse, Occitanie, France

Site Status

Hopitaux Universitaires Henri Mondor - Hopital Henri Mondor /ID# 230358

Créteil, Paris, France

Site Status

Hôpital Saint-Louis /ID# 232067

Paris, Paris, France

Site Status

CHU de Nantes, Hotel Dieu -HME /ID# 245928

Nantes, Pays de la Loire Region, France

Site Status

Centre Leon Berard /ID# 230348

Lyon, Rhone, France

Site Status

HCL - Hopital Lyon Sud /ID# 231449

Pierre-Bénite, Rhone, France

Site Status

CHD Vendée- La Roche-sur-Yon - Les Oudairies /ID# 234095

La Roche-sur-Yon, Vendee, France

Site Status

CHU Poitiers - La miletrie /ID# 230357

Poitiers, Vienne, France

Site Status

CHU de CAEN - Hopital de la Cote de Nacre /ID# 245929

Caen, , France

Site Status

Hopital Pitie Salpetriere /ID# 230360

Paris, Île-de-France Region, France

Site Status

Universitaetsklinikum Tuebingen /ID# 229663

Tübingen, Baden-Wurttemberg, Germany

Site Status

Universitaetsklinikum Wuerzburg /ID# 229278

Würzburg, Bavaria, Germany

Site Status

Universitaetsklinikum Giessen /ID# 234245

Giessen, Hesse, Germany

Site Status

Klinikum Kassel /ID# 229185

Kassel, Hesse, Germany

Site Status

Universitaetsmedizin Goettingen /ID# 230411

Göttingen, Lower Saxony, Germany

Site Status

Universitaetsklinikum Bonn /ID# 249401

Bonn, North Rhine-Westphalia, Germany

Site Status

Universitaetsklinikum Carl Gustav Carus Dresden /ID# 229754

Dresden, Saxony, Germany

Site Status

Universitaetsklinikum Leipzig /ID# 242907

Leipzig, Saxony, Germany

Site Status

Otto-von-Guericke-Universitaet /ID# 230144

Magdeburg, Saxony-Anhalt, Germany

Site Status

Helios Klinikum Berlin-Buch /ID# 229178

Berlin, State of Berlin, Germany

Site Status

Universitaetsklinikum Jena /ID# 232064

Jena, Thuringia, Germany

Site Status

Sozialstiftung Bamberg /ID# 229184

Bamberg, , Germany

Site Status

Universitaetsklinikum Essen /ID# 229180

Essen, , Germany

Site Status

Klinikum Mutterhaus der Borromäerinnen /ID# 232354

Trier, , Germany

Site Status

General Hospital of Athens Laiko /ID# 226626

Athens, Attica, Greece

Site Status

Alexandra General Hospital /ID# 226632

Athens, Attica, Greece

Site Status

University General Hospital Attikon /ID# 226629

Athens, Attica, Greece

Site Status

University General Hospital of Ioannina /ID# 226628

Ioannina, Ioannina, Greece

Site Status

General University Hospital of Thessaloniki AXEPA /ID# 226630

Thessaloniki, Thessaloniki, Greece

Site Status

Theageneio Anticancer Hospital /ID# 226627

Thessaloniki, Thessaloniki, Greece

Site Status

General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 226633

Athens, , Greece

Site Status

Semmelweis Egyetem /ID# 229291

Budapest, Budapest, Hungary

Site Status

Del-pesti Centrumkorhaz Orszagos Hematologiai es Infektologiai Intezet /ID# 229286

Budapest, Budapest, Hungary

Site Status

Debreceni Egyetem-Klinikai Kozpont /ID# 229287

Debrecen, Hajdú-Bihar, Hungary

Site Status

Somogy Varmegyei Kaposi Mor Oktato Korhaz /ID# 246475

Kaposvár, Somogy County, Hungary

Site Status

Szabolcs-Szatmar-Bereg Varmegyei Oktatokorhaz /ID# 232203

Nyíregyháza, Szabolcs-Szatmár-Bereg, Hungary

Site Status

Szegedi Tudományegyetem /ID# 229289

Szeged, Szeged, Hungary

Site Status

Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz /ID# 229290

Szombathely, Vas County, Hungary

Site Status

Orszagos Onkologiai Intezet /ID# 229292

Budapest, , Hungary

Site Status

Yitzhak Shamir Medical Center /ID# 228037

Ẕerifin, Central District, Israel

Site Status

Rambam Health Care Campus /ID# 227849

Haifa, Haifa District, Israel

Site Status

Hadassah /ID# 227846

Jerusalem, Jerusalem, Israel

Site Status

ZIV Medical Center /ID# 232257

Safed, Northern District, Israel

Site Status

The Chaim Sheba Medical Center /ID# 228322

Ramat Gan, Tel Aviv, Israel

Site Status

Tel Aviv Sourasky Medical Center /ID# 228529

Tel Aviv, Tel Aviv, Israel

Site Status

Rabin Medical Center /ID# 228043

Petah Tikva, , Israel

Site Status

Azienda Ospedaliero - Universitaria SS. Antonio e Biagio e Cesare Arrigo - Aless /ID# 227401

Alessandria, Alessandria, Italy

Site Status

Duplicate_I.R.C.C.S Istituto Tumori Giovanni Paolo II /ID# 227400

Bari, Bari, Italy

Site Status

ASST degli Spedali Civili di Brescia /ID# 227397

Brescia, Brescia, Italy

Site Status

Fondazione di Religione e di Culto Casa Sollievo della Sofferenza /ID# 228458

San Giovanni Rotondo, Foggia, Italy

Site Status

IRCCS Ospedale San Raffaele /ID# 228669

Milan, Milano, Italy

Site Status

Istituto Europeo Di Oncologia /ID# 227396

Milan, Milano, Italy

Site Status

Duplicate_Azienda Ospedaliera Universitaria Federico II /ID# 230403

Napoli, Napoli, Italy

Site Status

Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello /ID# 227402

Palermo, Palermo, Italy

Site Status

A.O.U. CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO - Ospedale Molinette /ID# 229820

Turin, Piedmont, Italy

Site Status

Duplicate_Centro di Riferimento Oncologico /ID# 227395

Aviano, Pordenone, Italy

Site Status

Ospedale Santa Maria Delle Croci /ID# 227394

Ravenna, Ravenna, Italy

Site Status

Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Università Cattolica /ID# 230402

Rome, Roma, Italy

Site Status

Istituto di Candiolo Fondazione del Piemonte per l'Oncologia IRCCS /ID# 229602

Candiolo, Torino, Italy

Site Status

Azienda Ospedaliero Universitaria Maggiore della Carita di Novara /ID# 227399

Novara, , Italy

Site Status

Duplicate_NHO Nagoya Medical Center /ID# 230678

Nagoya, Aichi-ken, Japan

Site Status

Aichi Cancer Center Hospital /ID# 230134

Nagoya, Aichi-ken, Japan

Site Status

Fujita Health University Hospital /ID# 264541

Toyoake, Aichi-ken, Japan

Site Status

National Cancer Center Hospital East /ID# 232423

Kashiwa-shi, Chiba, Japan

Site Status

Matsuyama Red Cross Hospital /ID# 251866

Matsuyama, Ehime, Japan

Site Status

National Hospital Organization Kyushu Cancer Center /ID# 252245

Fukuoka, Fukuoka, Japan

Site Status

Kyushu University Hospital /ID# 230136

Fukuoka, Fukuoka, Japan

Site Status

Fukushima Medical University Hospital /ID# 251839

Fukushima, Fukushima, Japan

Site Status

Hokkaido University Hospital /ID# 231443

Sapporo, Hokkaido, Japan

Site Status

Kobe City Medical Center General Hospital /ID# 251945

Kobe, Hyōgo, Japan

Site Status

Kagoshima University Hospital /ID# 232251

Kagoshima, Kagoshima-ken, Japan

Site Status

Tokai University Hospital /ID# 252135

Isehara, Kanagawa, Japan

Site Status

Kitasato University Hospital /ID# 264668

Sagamihara-shi, Kanagawa, Japan

Site Status

Kyoto University Hospital /ID# 231156

Kyoto, Kyoto, Japan

Site Status

Mie University Hospital /ID# 251944

Tsu, Mie-ken, Japan

Site Status

Tohoku University Hospital /ID# 232303

Sendai, Miyagi, Japan

Site Status

Shinshu University Hospital /ID# 252246

Matsumoto-shi, Nagano, Japan

Site Status

Okayama University Hospital /ID# 232009

Okayama, Okayama-ken, Japan

Site Status

Osaka City General Hospital /ID# 264670

Osaka, Osaka, Japan

Site Status

Kindai University Hospital /ID# 232152

Osakasayama-shi, Osaka, Japan

Site Status

National Cancer Center Hospital /ID# 230004

Chuo-ku, Tokyo, Japan

Site Status

The Cancer Institute Hospital Of JFCR /ID# 230271

Koto-ku, Tokyo, Japan

Site Status

Yamagata University Hospital /ID# 230005

Yamagata, Yamagata, Japan

Site Status

Yamanashi Prefectural Central Hospital /ID# 263715

Kofu, Yamanashi, Japan

Site Status

Canisius-Wilhelmina Ziekenhuis /ID# 248138

Nijmegen, Gelderland, Netherlands

Site Status

Amphia Ziekenhuis /ID# 247739

Breda, North Brabant, Netherlands

Site Status

Olvg /Id# 247899

Amsterdam, North Holland, Netherlands

Site Status

Dijklander Ziekenhuis /ID# 248993

Hoorn, North Holland, Netherlands

Site Status

Medisch Spectrum Twente /ID# 247854

Enschede, Overijssel, Netherlands

Site Status

Universitair Medisch Centrum Groningen /ID# 247741

Groningen, Provincie Groningen, Netherlands

Site Status

Albert Schweitzer Ziekenhuis /ID# 247740

Dordrecht, South Holland, Netherlands

Site Status

Leids Universitair Medisch Centrum /ID# 247742

Leiden, South Holland, Netherlands

Site Status

Franciscus Gasthuis & Vlietland, Locatie Gasthuis /ID# 248139

Rotterdam, South Holland, Netherlands

Site Status

St. Antonius Ziekenhuis /ID# 248644

Nieuwegein, Utrecht, Netherlands

Site Status

Admiraal de Ruyter Ziekenhuis /ID# 247692

Goes, Zeeland, Netherlands

Site Status

Deventer Ziekenhuis /ID# 247853

Deventer, , Netherlands

Site Status

Aotearoa Clinical Trials /ID# 228509

Papatoetoe, Auckland, New Zealand

Site Status

North Shore Hospital /ID# 228508

Takapuna, Auckland, New Zealand

Site Status

Palmerston North Hospital /ID# 232352

Palmerston North, Manawatu-Wanganui, New Zealand

Site Status

ARS-MEDICAL Sp. z o.o. /ID# 229601

Piła, Greater Poland Voivodeship, Poland

Site Status

Aidport Sp. z o.o. /ID# 229299

Skórzewo, Greater Poland Voivodeship, Poland

Site Status

Pratia MCM Krakow /ID# 229121

Krakow, Lesser Poland Voivodeship, Poland

Site Status

Szpitale Pomorskie Sp. z o.o /ID# 229122

Gdynia, Pomeranian Voivodeship, Poland

Site Status

Swietokrzyskie Centrum Onkologii Samodzielny Publiczny Zaklad Opieki Zdrowotnej /ID# 229362

Kielce, Świętokrzyskie Voivodeship, Poland

Site Status

Hematology and Oncology Institute /ID# 230056

Manatí, Puerto Rico, Puerto Rico

Site Status

Pan American Center for Oncology Trials, LLC /ID# 230055

Rio Piedras, Puerto Rico, Puerto Rico

Site Status

Auxilio Mutuo Cancer Center /ID# 248721

San Juan, Puerto Rico, Puerto Rico

Site Status

Narodny onkologicky ustav /ID# 239510

Bratislava, Bratislava Region, Slovakia

Site Status

Wits Clinical Research /ID# 228895

Johannesburg, Gauteng, South Africa

Site Status

Alberts Cellular Therapy /ID# 228896

Pretoria, Gauteng, South Africa

Site Status

University of Cape Town /ID# 228900

Cape Town, Western Cape, South Africa

Site Status

Haemalife Inc. /ID# 243392

Kuils River, Western Cape, South Africa

Site Status

Inje University - Busan Paik Hospital /ID# 230293

Busan, Busan Gwang Yeogsi, South Korea

Site Status

Dong-A University Medical Center /ID# 228638

Busan, Busan Gwang Yeogsi, South Korea

Site Status

Pusan National University Hospital /ID# 229798

Busan, Busan Gwang Yeogsi, South Korea

Site Status

Seoul National University Bundang Hospital /ID# 228448

Seongnam-si, Gyeonggido, South Korea

Site Status

Keimyung University Dongsan Hospital /ID# 229800

Daegu, Gyeongsangbuk-do, South Korea

Site Status

Jeonbuk National University Hospital /ID# 228908

Jeonju, Jeonrabugdo, South Korea

Site Status

Seoul National University Hospital /ID# 228446

Seoul, Seoul Teugbyeolsi, South Korea

Site Status

Asan Medical Center /ID# 228444

Seoul, Seoul Teugbyeolsi, South Korea

Site Status

Samsung Medical Center /ID# 228445

Seoul, Seoul Teugbyeolsi, South Korea

Site Status

The Catholic University of Korea, Seoul St. Marys Hospital /ID# 228447

Seoul, Seoul Teugbyeolsi, South Korea

Site Status

Instituto Catalan de Oncologia (ICO) Badalona /ID# 228108

Badalona, Barcelona, Spain

Site Status

Hospital Parc de Salut del Mar /ID# 228106

Barcelona, Barcelona, Spain

Site Status

Hospital Santa Creu i Sant Pau /ID# 229859

Barcelona, Barcelona, Spain

Site Status

Institut Català d'Oncologia (ICO) - L'Hospitalet /ID# 228107

L'Hospitalet de Llobregat, Barcelona, Spain

Site Status

Hospital San Pedro de Alcantara /ID# 248845

Cáceres, Caceres, Spain

Site Status

Hospital Universitario Marques de Valdecilla /ID# 228984

Santander, Cantabria, Spain

Site Status

Hospital Universitario Reina Sofia /ID# 228122

Córdoba, Cordoba, Spain

Site Status

CLINICA UNIVERSIDAD DE NAVARRA-Madrid /ID# 229157

Madrid, Madrid, Spain

Site Status

MD Anderson Madrid /ID# 229860

Madrid, Madrid, Spain

Site Status

Hospital Universitario Ramon y Cajal /ID# 228113

Madrid, Madrid, Spain

Site Status

Hospital Universitario Fundacion Jimenez Diaz /ID# 228110

Madrid, Madrid, Spain

Site Status

Hospital Universitario 12 de Octubre /ID# 228109

Madrid, Madrid, Spain

Site Status

Clinica Universidad de Navarra - Pamplona /ID# 228116

Pamplona, Navarre, Spain

Site Status

Hospital Universitario de Salamanca /ID# 228117

Salamanca, Salamanca, Spain

Site Status

Hospital Universitario Virgen del Rocio /ID# 228118

Seville, Sevilla, Spain

Site Status

Sunderby sjukhus /ID# 228165

Luleå, Norrbotten County, Sweden

Site Status

Sodra Alvsborgs sjukhus /ID# 228886

Borås, Västra Götaland County, Sweden

Site Status

Linkoping University Hospital /ID# 233520

Linköping, Östergötland County, Sweden

Site Status

Kantonsspital Aarau AG /ID# 229113

Aarau, Canton of Aargau, Switzerland

Site Status

Kantonsspital St. Gallen /ID# 229117

Sankt Gallen, Canton of St. Gallen, Switzerland

Site Status

EOC Ospedale Regionale di Bellinzona e Valli /ID# 228922

Bellinzona, Canton Ticino, Switzerland

Site Status

Kantonsspital Graubünden /ID# 253862

Chur, Kanton Graubünden, Switzerland

Site Status

Kaohsiung Chang Gung Memorial Hospital /ID# 227384

Kaohsiung City, Kaohsiung, Taiwan

Site Status

China Medical University Hospital /ID# 227379

Taichung, Taichung, Taiwan

Site Status

Taichung Veterans General Hospital /ID# 227383

Taichung, Taichung, Taiwan

Site Status

National Cheng Kung University Hospital /ID# 227381

Tainan City, Tainan, Taiwan

Site Status

Ankara Universitesi Fakultesi /ID# 227790

Ankara, Ankara, Turkey (Türkiye)

Site Status

Istanbul Universitesi-Cerrahpasa Cerrahpasa Tip Fakultesi /ID# 248202

Istanbul, Istanbul, Turkey (Türkiye)

Site Status

Istanbul Florence Nightingale Hastanesi /ID# 229546

Istanbul, Istanbul, Turkey (Türkiye)

Site Status

Duplicate_Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi /ID# 227855

Istanbul, Istanbul, Turkey (Türkiye)

Site Status

Ege University Medical Faculty /ID# 227792

Izmir, İzmir, Turkey (Türkiye)

Site Status

Kocaeli University Med Faculty /ID# 227854

Köseköy, Kocaeli, Turkey (Türkiye)

Site Status

Ondokuz mayis University Facul /ID# 227794

Samsun, Samsun, Turkey (Türkiye)

Site Status

Akdeniz Universitesi Tip Fakul /ID# 227791

Antalya, , Turkey (Türkiye)

Site Status

Dicle Universitesi Tip /ID# 230087

Diyarbakır, , Turkey (Türkiye)

Site Status

University Hospitals Birmingham NHS Foundation Trust /ID# 230043

Birmingham, Birmingham, United Kingdom

Site Status

Derriford Hospital and the Royal Eye Infirmary /ID# 230038

Plymouth, Devon, United Kingdom

Site Status

Gartnavel General Hospital /ID# 230027

Glasgow, Glasgow City, United Kingdom

Site Status

Disc_Barts Health NHS Trust - The Royal London Hospital /ID# 230028

London, Greater London, United Kingdom

Site Status

Clatterbridge Cancer Centre - Liverpool /ID# 230036

Liverpool, Liverpool, United Kingdom

Site Status

The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 230123

Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom

Site Status

Oxford University Hospitals NHS Foundation Trust /ID# 230035

Oxford, Oxfordshire, United Kingdom

Site Status

Leeds Teaching Hospitals NHS Trust /ID# 230471

Leeds, West Yorkshire, United Kingdom

Site Status

East Suffolk and North Essex NHS Foundation Trust /ID# 230040

Colchester, , United Kingdom

Site Status

The Christie Hospital /ID# 230124

Manchester, , United Kingdom

Site Status

Portsmouth Hospitals University NHS Trust /ID# 230044

Portsmouth, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Austria Belgium Brazil Canada China Czechia Denmark France Germany Greece Hungary Israel Italy Japan Netherlands New Zealand Poland Puerto Rico Slovakia South Africa South Korea Spain Sweden Switzerland Taiwan Turkey (Türkiye) United Kingdom

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-505628-67

Identifier Type: OTHER

Identifier Source: secondary_id

M20-638

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.